Prevalence, Characteristics, and Clinical Course of Neuropathic Pain in Primary Care Patients Consulting With Low Back-related Leg Pain

Abstract

Objectives: Little is known about the epidemiology of neuropathic pain in primary care patients consulting with low back-related leg pain. We aimed to describe prevalence, characteristics, and clinical course of low back-related leg pain patients with and without neuropathic pain, consulting with their family doctor in the United Kingdom. Materials and Methods: This was a prospective cohort study. Data were collected using a standardized baseline clinical examination and self-report questionnaires at baseline, 4, 12, and 36 months. We identified cases of neuropathic pain using 3 definitions: 2 based on clinical diagnosis (sciatica, with and without evidence of nerve root compression on magnetic resonance imaging), one on the self-report version of Leeds Assessment for Neurological Symptoms and Signs. Differences between patients with and without neuropathic pain were analyzed comparing each definition. Clinical course (mean pain intensity measured as the highest of leg or back pain intensity: mean of 3 Numerical Rating Scales, each 0 to 10) was investigated using linear mixed models over 36 months. Results: Prevalence of neuropathic pain varied from 48% to 74% according to definition used. At baseline, patients with neuropathic pain had more severe leg pain intensity, lower pain self-efficacy, more patients had sensory loss than those without. Distinct profiles were apparent depending on neuropathic pain definition. Mean pain intensity reduced after 4 months (6.1 to 3.9 [sciatica]), most rapidly in cases defined by clinical diagnosis. Discussion: This research provides new information on the clinical course of neuropathic pain and a better understanding of neuropathic pain in low back-related leg pain patients consulting in primary care.

New Vistas in microRNA Regulatory Interactome in Neuropathic Pain

“…Neuropathic pain affects 20-26.4% of diabetic patients (Bouhassira et al, 2013) and 20% of patients with herpes zoster in the United States (Johnson and Rice, 2014;Saguil et al, 2017). 48-74% patients with low back-related leg pain (Harrisson et al, 2020) and 40% of people after surgery suffer from neuropathic pain (Johansen et al, 2012). Studies have found that about 8.1-17.9% of the Canadian population is affected by neuropathic pain (VanDenKerkhof et al, 2016).…”

Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012–2019

“…These conditions were chosen because they are among the most common pain conditions, could be wellidentified in claims data, and had historically been treated with opioids as the recommended first line therapy prior recent guideline modifications [17]. Individuals were considered to have CNCP only in calendar years in which they met these criteria, due to fluctuations in pain symptoms over time for many chronic pain conditions [30][31][32][33]. We also identified individuals with a cancer diagnosis in each calendar year, excluding skin cancer diagnoses.…”

Neural management plus advice to stay active on clinical measures and sciatic neurodynamic for patients with chronic sciatica: Study protocol for a controlled randomised clinical trial

“…Patients with chronic LBP usually present co-occurring pain [2]. In primary care, the prevalence of patients with back-related leg pain varied from 48% to 74% depending on the used description [3]. Sciatica is also known as lumbosacral radiculopathy that presents as a severe form of LBP characterised by radiating leg pain and is considered chronic when symptoms last more than 12 weeks [4].…”